- Published at
- by manilatimes.net
positive
positive
News for Theralink Technologies, Inc. (OBMP)
- Published at
- by globenewswire.com
mixedmixedIMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative...- Published at
- by investing.com
positivepositiveIMAC Holdings regains compliance with Nasdaq equity rule By Investing.com
IMAC Holdings regains compliance with Nasdaq equity rule- Published at
- by investing.com
mixedmixedIMAC Holdings regains Nasdaq compliance with strategic moves By Investing.com
IMAC Holdings regains Nasdaq compliance with strategic moves- Published at
- by globenewswire.com
mixedmixedIMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business
FRANKLIN, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- On May 1, 2024, as previously announced, pursuant to that certain Settlement and Release Agreement, by...- Published at
- by marketscreener.com
negativenegativeTheralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
Theralink Technologies, Inc. reported earnings results for the full year ended September 30, 2023. For the full year, the company reported sales was USD 0.606796 million compared to USD 0.567905...- Published at
- by globenewswire.com
mixedmixedTheralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies (OTC: THER), a precision oncology company with an...- Published at
- by globenewswire.com
mixedmixedTheralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
Golden, Colorado & Nashville, Tennessee, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision...- Published at
- by globenewswire.com
neutralneutralTheralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
Golden, Colorado, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision oncology company with its...- Published at
- by investing.com
mixedmixedIMAC Holdings Announces $4.3M Private Placement of Preferred Stock and Warrants By Investing.com
IMAC Holdings Announces $4.3M Private Placement of Preferred Stock and Warrants